FORM 6-K

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of November 2019

Commission File Number: 001-38757

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(Translation of registrant’s name into English)

1-1, Nihonbashi-Honcho 2-Chome

Chuo-ku, Tokyo 103-8668

Japan

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Information furnished on this form:

EXHIBIT

Exhibit Number
1.	Takeda to Host R&D Day & Plasma-Derived Therapies Day in Tokyo, Japan
99.1	Takeda R&D Day 2019 Presentation
99.2	Takeda PDT Day 2019 Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TAKEDA PHARMACEUTICAL COMPANY LIMITED
Date: November 21, 2019	By:	/s/ Takashi Okubo
		Takashi Okubo Global Head of Investor Relations

Takeda Information

Takeda to Host R&D Day & Plasma-Derived Therapies Day in Tokyo, Japan

Osaka, JAPAN, November 21,2019 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) will host a combined R&D Day and Plasma-Derived Therapies (PDT) Day on November 21, 2019 in Tokyo, Japan, from 11:00 a.m. to 5:00 p.m. JST, for investors and analysts. The Japanese and English language versions of the R&D Day presentation and PDT Day presentation, which include contents that were presented in New York on November 14 and in Covington on November 15, respectively, are attached.

Also, a webcast of the event will be made available on the FY19 Special IR Events section at https://www.takeda.com/investors/reports/quarterly-announcements/quarterly-announcements-2019/.

# # #

4